Renal hemodynamics in patients with resistant hypertension and type 2 diabetes mellitus

被引:0
|
作者
Manukyan, M. A. [1 ]
Yu, Falkovskaya A. [1 ]
Zyubanova, I., V [1 ]
Solonskaya, E., I [1 ]
Lichikaki, V. A. [1 ]
Ryabova, T. R. [1 ]
Vtorushina, A. A. [1 ]
Hunkhinova, S. A. [1 ]
Skomkina, I. A. [1 ]
Yevtukh, A. A. [1 ]
Gusakova, A. M. [1 ]
Mordovin, V. F. [1 ]
机构
[1] Russian Acad Sci, Cardiol Res Inst, Tomsk Natl Res Ctr, Tomsk, Russia
关键词
Resistant arterial hypertension; type 2 diabetes mellitus; renal hemodynamics; renal arterial resistive index; CENTRAL PULSE PRESSURE; VASCULAR DAMAGE; ORGAN DAMAGE; INDEX; ULTRASOUND; ALBUMINURIA; POPULATION; STIFFNESS; PREDICTS;
D O I
10.18087/cardio.2023.8.n2468
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim To study renal hemodynamics in patients with resistant arterial hypertension (RAH) in combination with type 2 diabetes mellitus (DM2) and to identify factors involved in the increase in intrarenal vascular resistance. Material and methods This study included 59 patients (25 men) with RAH in combination with DM2. Mean age of patients was 60.3 +/- 7.9 years; 24-h blood pressure (24-BP) (systolic, diastolic, SBP /DBP) was 158.0 +/- 16.3/82.5 +/- 12.7 mm Hg during the treatment with 4.3 [4.0;5.0] antihypertensive drugs; glycated hemoglobin (HbA1c) was 7.5 +/- 1.5%; estimated glomerular filtration rate (eGFR) was 73.1 +/- 21.8 ml / min/ 1.73 m(2) (CKD-EPI equation). Measurement of office BP, 24-h BP monitoring, renal artery (RA) Doppler, routine lab tests including determination of GFR (CKD-EPI), 24-h urine albumin excretion, and ELISA measurement of blood lipocalin-2, cystatin C, high-sensitive C-reactive protein ( hsCRP), and asymmetric dimethylarginine (ADMA) were performed for all patients. Results Incidence of increased RA resistive index (RI) was 39 % despite the high rate of vasodilator treatment (93 % for renin-angiotensin-aldosterone system inhibitors, 78% for calcium antagonists). According to a correlation and regression analysis, RA RI values were correlated with the kidney function (r=-0.46, p<0.001 for eGFR, r=0.56; p=0.006 for lipocalin-2), age (r=0.54, p<0.001), increases in concentrations of hsCRP (r=0.35, p<0.001) and ADMA (r=0.39, p=0.028), the increase in vascular stiffness (r=0.59, p<0.001 for pulse BP (PBP) as well as DM2 duration, and HbA1c (r=0.33, p<0.001 for both). The independent association of RA RI with the age, PBP, and duration of DM2 was confirmed by the results of multivariate regression analysis. According to the ROC analysis, the threshold level of RA RI corresponding to a decrease in GFR <60 ml/min /1.73 m(2) was >= 0.693 conv. units. Conclusion In more than one third of patients with RAH in combination with DM2, increased renal vascular resistance was documented, which was closely associated with impaired kidney function, age, DM2 duration and severity, and markers of low-grade inflammation, endothelial dysfunction, and vascular stiffness. The value of RA RI >= 0.693 conv. units was a threshold for the development of chronic kidney disease (CKD).
引用
收藏
页码:42 / 49
页数:7
相关论文
共 50 条
  • [1] RENAL HEMODYNAMICS AFTER RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS
    Falkovskaya, A.
    Mordovin, V.
    Pekarskiy, S.
    Semke, G.
    Ripp, T.
    Zyubanova, I.
    Lichikaki, V.
    Baev, A.
    Ryabova, T.
    JOURNAL OF HYPERTENSION, 2017, 35 : E216 - E217
  • [2] Predictors of antihypertensive efficiency of renal denervation in patients with resistant hypertension and type 2 diabetes mellitus
    Manukyan, M.
    Falkovskaya, A.
    Mordovin, V.
    Zyubanova, I.
    Tsoi, E.
    Ryabova, T.
    Pekarskiy, S.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2374 - 2374
  • [3] THE EFFECT OF RENAL DENERVATION ON INFLAMMATORY MARKERS IN PATIENTS WITH RESISTANT HYPERTENSION AND DIABETES MELLITUS TYPE 2
    Falkovskaya, A.
    Mordovin, V.
    Pekarskiy, S.
    Baev, A.
    Semke, G.
    Ripp, T.
    Zyubanova, I.
    Kravtchenko, E.
    JOURNAL OF HYPERTENSION, 2016, 34 : E175 - E175
  • [4] NATRIURESIS AS A MARKER OF RENAL DENERVATION EFFECTIVENESS FOR PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS
    Falkovskaya, A.
    Mordovin, V.
    Pekarskiy, S.
    Baev, A.
    Semke, G.
    Ripp, T.
    Sytkova, E.
    Lichikaki, V.
    JOURNAL OF HYPERTENSION, 2015, 33 : E495 - E495
  • [5] Resistant Hypertension Prevalence in Type 2 Diabetes Mellitus: Relationship to Renal Function
    Weinrauch, Larry A.
    Segal, Alissa
    Wisniewski, Eric
    D'Elia, John A.
    DIABETES, 2015, 64 : A615 - A615
  • [6] CEREBROVASCULAR DISORDERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND RESISTANT HYPERTENSION
    Falkovskaya, Alla Yu
    Mordovin, Victor F.
    Sukhareva, Anna E.
    Zyubanova, Irina, V
    Manukyan, Musheg A.
    Lichikaki, Valeriya A.
    Tsoi, Ekaterina, I
    Gusakova, Anna M.
    Dorozhkina, Natalya, V
    DIABETES MELLITUS, 2022, 25 (02): : 128 - 135
  • [7] LEPTIN AS A PREDICTOR OF CARDIOPROTECTIVE EFFICIENCY OF RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS
    Manukyan, Musheg
    Falkovskaya, Alla
    Mordovin, Victor
    Zyubanova, Irina
    Tsoy, Ekaterina
    Pekarskiy, Stanislav
    Ryabova, Tamara
    Khunkhinova, Simzhit
    Vtorushina, Anastasia
    Gusakova, Anna
    Suslova, Tatiana
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E244 - E244
  • [8] THE EFFECT OF RENAL DENERVATION ON PERIPHERAL AND CEREBRAL VASOREACTIVITY IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS
    Falkovskaya, Alla
    Mordovin, V.
    Pekarskiy, S.
    Manukyan, M.
    Zyubanova, I.
    Lichikaki, V.
    Tsoy, E.
    Vtorushina, A.
    Khunkhinova, S.
    Shalishev, I.
    Triss, S.
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E244 - E244
  • [9] DYNAMICS OF GLYCEMIC CONTROL AFTER RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS
    Falkovskaya, A. Yu.
    Mordovin, V. F.
    Pekarsky, S. Ye.
    Bayev, A. Ye.
    Semke, G. V.
    Ripp, T. M.
    Kravtchenko, Ye. S.
    Zyubanova, I. V.
    BYULLETEN SIBIRSKOY MEDITSINY, 2015, 14 (05): : 83 - 90
  • [10] ASSOCIATION OF MATRIX METALLOPROTEINASES WITH THE RENAL BLOOD FLOW AND RENAL FUNCTION IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS
    Falkovskaya, Alla
    Mordovin, Victor
    Pekarskyi, Stanislav
    Semke, Galina
    Ripp, Tatyana
    Zyubanova, Irina
    Ryabova, Tamara
    Gusakova, Anna
    JOURNAL OF HYPERTENSION, 2016, 34 : E117 - E117